Aerie
is a North Carolina-based pharmaceutical company that develops and commercializes novel therapies to treat open-angle glaucoma, ocular surface, and retinal diseases... Read moreAerie
is a North Carolina-based pharmaceutical company that develops and commercializes novel therapies to treat open-angle glaucoma, ocular surface, and retinal diseases... Read more
News
Apr 10, 2024
Pharamceutical Technology
Aerie: Aerie Pharmaceuticals gets grant for ocular disorder treatment using amino isoquinolinyl amide compounds
Dec 01, 2022
VisionMonday
Aerie: Alcon Completes Acquisition of Aerie Pharmaceuticals
Nov 15, 2022
Seeking Alpha
Aerie: Aerie Pharmaceuticals last day of trading expected Nov. 18 as part of Alcon merger
Nov 07, 2022
MarketScreener
Aerie: Aerie Pharmaceuticals : Merger Agreement - Form 8-K
Nov 04, 2022
Owler
Aerie Pharmaceuticals, Inc.: Aerie's revenue changed from $207.12M in Jun 2022 to $213.94M in Sep 2022
Oct 17, 2022
PR Newswire
Press Release: Aerie : SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSVI, AERI, BTRS, POSH
Oct 05, 2022
PR Newswire
Press Release: Aerie : SHAREHOLDER ALERT: Weiss Law Reminds AERI, RCOR, STOR, and LOTZ Shareholders About Its Ongoing Investigations
Sep 27, 2022
MarketScreener
Aerie: AERIE PHARMACEUTICALS - INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. - AERI
Aug 30, 2022
Benzinga
Aerie: SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Aerie Pharmaceuticals, Inc. (Nasdaq - AERI)
Aug 26, 2022
Global Legal Chronicle
Aerie: Alcon's Acquisition of Aerie Pharmaceuticals
Aerie Competitors
1
2
3
4
5
6
7
8
9
10